Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Executives believe the market for electric vehicles is about to see a rebound in demand as prices come down.
Boeing announced 17,000 layoffs, a delay to the launch of its 777X passenger jet, and billions in charges related to ongoing strikes.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
As the takeover bid from Couche-Tard heats up, Seven & i Holdings announced a plan to split its business in two.
IBM may want to use household appliances to track users and time ads.
UnitedHealth, CVS, and Cigna want FTC chair Lina Khan and two other officials recused from their case due to alleged biases.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Oil giants Chevron and BP made moves to refine their business, drilling down on core segments that crude demand assures will be worth it.
Amazon’s patent to help doctors take better notes highlights the company’s massive bet on the healthcare space.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.